Bioavailability Studies and in vitro Profiling of the Selective Excitatory Amino Acid Transporter Subtype 1 (EAAT1) Inhibitor UCPH-102

ChemMedChem
Isabell HaymLennart Bunch

Abstract

Although the selective excitatory amino acid transporter subtype 1 (EAAT1) inhibitor UCPH-101 has become a standard pharmacological tool compound for in vitro and ex vivo studies in the EAAT research field, its inability to penetrate the blood-brain barrier makes it unsuitable for in vivo studies. In the present study, per os (p.o.) administration (40 mg kg(-1) ) of the closely related analogue UCPH-102 in rats yielded respective plasma and brain concentrations of 10.5 and 6.67 μm after 1 h. Three analogue series were designed and synthesized to improve the bioavailability profile of UCPH-102, but none displayed substantially improved properties in this respect. In vitro profiling of UCPH-102 (10 μm) at 51 central nervous system targets in radioligand binding assays strongly suggests that the compound is completely selective for EAAT1. Finally, in a rodent locomotor model, p.o. administration of UCPH-102 (20 mg kg(-1) ) did not induce acute effects or any visible changes in behavior.

References

May 20, 1999·Annual Review of Pharmacology and Toxicology·R P Seal, S G Amara
May 23, 2001·Progress in Neurobiology·N C Danbolt
Oct 26, 2002·The Journal of Organic Chemistry·J Gonzalo Rodríguez, J Luis Tejedor
Nov 5, 2002·Biopharmaceutics & Drug Disposition·J Cory Kalvass, Tristan S Maurer
Apr 5, 2007·The Journal of Pharmacology and Experimental Therapeutics·Scott G SummerfieldPhil Jeffrey
Jan 24, 2009·Journal of Medicinal Chemistry·Anders A JensenLennart Bunch
Sep 8, 2011·Chemistry : a European Journal·Thorsten H Wöste, Martin Oestreich
Mar 8, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Timotheus BudisantosoRyuichi Shigemoto
Mar 14, 2012·The Journal of Physiology·Nneka M UwechueBrian Billups
Oct 19, 2013·Physiological Reviews·Robert J Vandenberg, Renae M Ryan

❮ Previous
Next ❯

Citations

Nov 28, 2019·Journal of Medicinal Chemistry·Wesley WangChristopher G Parker
May 31, 2020·Trends in Pharmacological Sciences·Marco NielloHarald H Sitte

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.